Leishmaniasis 
Dr.Pragati MD 
Dr.Rubina MD 
1
What is Kala-Azar 
• Kala-azar means dark pigmentation which is 
characteristic of cases of visceral 
leishmaniasis. It is caused by Leishmania 
donovani bodies and may be present either in 
endemic, epidemic or sporadic forms. It is 
widely prevalent in India in epidemic form in 
states of Bihar, Assam and Bengal. Kala azar 
found in East and North Africa is a disease of 
young children and young adults, being more 
common in males as compared to females. 
2
World distribution 
of Visceral Leishmaniasis 
3
SYNONYMS 
kala azar, black fever, sandfly disease, 
Dum-Dum fever 
4
KALA AZAR 
• Leishmaniasis is a disease caused by protozoan 
parasites of to the genus Leishmania and is 
transmitted by the bite of sand fly. 
• Human infection is caused by about 21 of 30 
species that infect mammals. These include the L. 
donovani complex with three species (L. donovani, 
L. infantum, and L. chagasi 
5
Pathogenesis 
• Infections range from asymptomatic to progressive, 
fully developed kala-azar. 
• Incubation period is usually 2 – 4 months. 
• Symptoms – Begins with low-grade fever and 
malaise, followed by progressive wasting, anemia, 
and protrusion of the abdomen from enlarged liver 
and spleen. 
• Fatal after 2 – 3 years if not treated. 
• In acute cases with chills, fevers up to 104⁰ F and 
vomiting; death may occur within 6 – 12 months. 
• Immediate cause of death is usually an invasion of a 
secondary pathogen that the body is unable to 
combat. 
6
Leishmaniasis is Neglected Disease 
• Leishmaniasis is a globally important but 
neglected disease, affecting 
approximately two million people every 
year. For most people, infection results in 
a slow-to-heal skin ulcer. In others, 
however, the parasite targets the liver, 
spleen and bone marrow, leading to over 
70,000 deaths annually. 
7
The Parasite 
• Phylum 
• Order 
• Family 
• Genus 
Sarcomastigophora 
Kinetoplastida 
Trypanosomatidae 
Leishmania 
8
Leishmania Parasites and Diseases 
SPECIES Disease 
Leishmania tropica* 
Leishmania major* 
Cutaneous leishmaniasis 
Leishmania aethiopica 
Leishmania mexicana 
Leishmania braziliensis Mucocutaneous leishmaniasis 
Visceral leishmaniasis 
Leishmania donovani* 
Leishmania infantum* 
Leishmania chagasi 
9
CLASSIFICATION 
Old world 
leishmaniasis 
• Leishmania donovani 
• L.infantum 
• L.tropica 
• L.major 
• L.aethiopica 
New world 
leishmaniasis 
• L.braziliensis 
• L.mexicana complex 
• L.peruviana 
• L.chagasi 
10
• ALL the leishmania species are 
morphologically identical to each other. 
• These are distinguished by 
• Intrinsic characters 
• Biochemical characters 
• Immunological characters 
11
Morphology 
• Promastigote • Amastigote 
Flagella 
Kinetoplast 
Golgi 
Nucleus 
Cytoskeleton 
12
Promastigote & Amastigote of 
Leishmania 
13
Morphology 
• Promastigote 
– Insect 
– Motile 
– Midgut 
• Amastigote 
– Mammalian stage 
– Non-motile 
– Intracellular 
Digenetic Life Cycle 
14
• Amastigotes (*) 
of Leishmania 
donovani in the 
cells of a 
spleen. The 
individual 
amastigotes 
measure 
approximately 1 
μm in diameter. 
15
Morphology and Life Cycle 
• Amastigotes 
measure 2-3 
micrometers, with a 
large nucleus and 
Kinetoplast. 
• Amastigotes mainly 
live within cells of 
the RE system, but 
have been found in 
nearly every tissue 
and fluid of the 
body. 
16
Life cycle 
• The organism is transmitted by the 
bite of several species of blood-feeding 
sand flies (Phlebotomus) 
which carries the promastigote in 
the anterior gut and pharynx. It 
gains access to mononuclear 
phagocytes where it transform into 
amastigote and divides until the 
infected cell ruptures. 
17
Sand fly- Vector 
18
Life cycle 
• The released organisms infect other 
cells. The sand-fly acquires the 
organisms during the blood meal, 
the Amastigote transform into 
flagellate Promastigote and multiply 
in the gut until the anterior gut and 
pharynx are packed. Dogs and 
rodents are common reservoirs. 19
Different stages of Haemoflagellates 
20
VL - Clinical Manifestation 
Variable - Incubation 3-100+ weeks 
Low grade fever 
Hepato-splenomegaly 
Bone marrow hyperplasia 
Anemia , Leucopenia & Cachexia 
Hypergammaglobulinemia 
Epistaxis , Proteinuria, Hematuria 
21
Hepatosplenomegaly 
in visceral leishmaniasis 
22
• Pallor in hands of a 
visceral 
leishmaniasis 
patient. 
23
Laboratory diagnosis 
• Blood counts: Anaemia, neutropenia, thrombocytopenia 
• A/G ratio reversed (n-4.5:2, in kala-azar-2.8:4) 
• Parasitological Diagnosis 
• PBF 
• Needle biopsy/aspiration 
• Culture 
• Animal inoculation 
• Immunological tests 
• Non-specific tests 
• Aldehyde tests 
• Antimony test 
• A:G Complement fixation test with W.K.K antigen 
24
• Immunological tests 
• Non-specific test 
• Aldehyde test 
• Antimony test 
• Complement fixation test with W.K.K antigen 
• Specific tests 
• Direct agglutination test(DAT) 
• Indirect haemagglutination test (IHA) 
• Indirect fluorescent antibody test(IFAT) 
• ELISA 
25
Parasitological diagnosis: 
Specimen : 
Bone marrow aspirate 
Splenic aspirate 
Lymph node aspiration 
Tissue biopsy 
Microscopy – PBF, Buffy coat smear 
Culture 
Animal inoculation- golden hamester 
26
Bone marrow aspiration 
Bone marrow amastigotes 
27
L. donovani bodies 
L. donovani bodies may be 
demonstrated in buffy 
coat preparations of 
blood and bone 
marrow aspirate. 
PBF is made with straight 
leucocytic edge 
Aspirates taken from 
enlarged lymph nodes 
show parasites in 60 
percent of cases. 
28
Culturing of the Parasite 
• Organisms can be 
cultured in Nicolle- 
NovyMcneal (NNN 
media) media from 
clinical specimens 
obtained from 
splenic or bone 
marrow aspirates. 
29
Cultivation 
• NNN medium-Biphasic media- 2 parts of salt 
agar+1 part of defibrinated rabbit blood, 
melted & cooled to 48⁰C ice, inoculated into 
water of condensation, incubated at 22-25⁰C 
for the 21 days. 
• Hockmeyer medium- Insect cell culture 
medium+ foetal calf serum+ penicillin+ 
streptomycin( detected after 2-3 d) 
• Schneider Dorsophila Medium 
30
Promastigote in culture in NNN 
medium (magnification 100×) 
NNN culture medium 
Promastigotes growing in culture medium Bone marrow aspirate -“rosette” of 
extra-cellular Promastigotes (Giemsa stain31).
Immunological Diagnosis: 
• Specific serologic tests: 
• Direct Agglutination Test (DAT), 
• ELISA, 
• IFAT, 
• CFT for detection of antibodies 
• Rapid immunochromatic test(ICT): By using 
rk39Ag 
• Molecular Methods: PCR & RT-PCR. 
32
Direct agglutination test 
• Direct agglutination test 
(DAT) based on 
agglutination of the 
trypsinized whole 
promastigotes is useful 
in endemic regions. Its 
sensitivity ranges from 
91-100% and specificity 
from 72 to 100%. 
33
ELISA 
• ELISA is an important 
sero diagnostic tool 
for leishmaniasis. It 
is a highly sensitive 
test and its 
specificity depends 
upon the antigen 
used. 
34
Chromatographic strip test 
• A ready to use immuno 
chromatographic strip 
test based on rk 39 
antigen has been 
developed as a rapid test 
for diagnosis of kala azar. 
An important limitation of 
this test is the presence 
of antibodies in healthy 
controls hailing from 
endemic regions. 
35
• Non specific serological tests for 
hypergammaglobinemia 
• Napier’s Aldehyde test: Patient’s sera is mixed 
with a drop of 40% formalin in a test tube. 
Positive test is indicated by jellification. 
• Chopra’s antimony test: Positive test is by 
formation of profuse flocculation when 
patient ‘ sera is mixed with 4% urea stilbamine 
solution. 
36
37 
Skin test ( leishmanin test or Montenegro 
test) It is a delayed hypersensitivity skin test 
for survey of populations and follow-up after 
treatment - 0.2 ml(6-10 million/ml of killed 
promastigotes in 0.5% phenol saline) 
injected—erythema ≥ 5mm→ +ve after 6-8 
weeks of cure.
The leishmanin skin test (LST) or MST (Montenegro skin test) 
PROBLEMS: 
A positive leishmanin skin test 
•Reference standards -antigens & performance (reading)- not developed. 
•Most antigens, crude extracts of parasites, neither sensitive nor specific. 
•Positivity not demonstrable until 5 months after the acute phase of VL-20% 
• May or may not be positive for PKDL. 
•Persistence of the lesions has been frequently associated with non reactivity in the 
LST and high levels of anti-leishmanial antibodies. 
38
Treatment: 
• Pentavalent antimony (Pentostam) 
• Amphotericin B 
• Miltefosine 
• Interferon 
Treatment of complications: 
• Anemia 
• Bleeding 
• Infections etc. 
39
Control 
• Vector control 
• Reservoir control 
• Treatment of active cases 
• Vaccination 
40
Management of Kala-azar Patients 
• It includes both supportive and curative. All 
patients of Kala azar should preferably be 
hospitalized. Any infection complicating the 
disease be treated by use of proper 
antibiotics. Nutrition must be maintained. 
Cases with severe anemia may require blood 
transfusions. Pentavalent antimony 
compounds are the drug of choice. Sodium 
antimony gluconate (Pentostam) is the most 
commonly used drug. 
41
Kala-azar prevention: 
• Multipronged approach is needed. 
• Sand-flies are extremely sensitive to 
insecticides & vector control through 
insecticide spray is very important. 
• Mosquito nets or curtains treated 
with insecticides will keep out the 
tiny sand-flies. 
42
Kala-azar prevention: 
• In endemic areas with zoonotic transmission, 
infected or stray dogs should be destroyed. 
• In areas with anthroponotic transmission, 
early diagnosis & treatment of human 
infections, to reduce the reservoir & control 
epidemics of VL, is extremely important. 
• Serology is useful for screening of suspected 
cases in the field. 
• No vaccine is currently available . 
43
• NLCP-National leishmania control programme 
is to eradicate leishmania by 2015. 
44
Post-kalazar dermal leishmaniasis 
(PKDL) 
45
Post Kala Azar Dermal 
Leishmanoid 
Normally develops <2 years after recovery 
Recrudescence 
Restricted to skin 
Rare but varies geographically(10% of cases 
in India and 3% of cases in Africa) 
46
PKDL 
•L.donovani 
•Non ulcerative skin lesin. 
•Late sequale of VL. 
•1-2 years after recovery fron VL. 
•Currently, PKDL is reported to occur in only 1% of Indian VL 
patient. 
Nodular skin lesions in PKDL 
•3 major representations- 
(i) Erythematous indurated lesions on the butterfly area of 
face; 
(ii) Multiple symmetrical hypopigmented macules with 
irregular margins that may coalesce, having generalized 
distribution to the extremities and trunk; and 
(iii) Combination of papules, nodules and plaques. 
47
Fig. Clinical presentation in PKDL (A) PKDL nodular and popular lesions on face and 
hypopigmented macules on neck in a patient 
with polymorphic presentation (B) hypopigmented macules on trunk in a patient with macular 
PKDL. (C) Erythematous and indurated 
lesions over the butterfly area of face. 48
Complications of PKDL 
1. Blindness due to corneal involvement. 
2. Recently, nerve involvement in Indian PKDL reportd. 
• Nowadays – reported from South America, Europe & India. 
• Recurrence of VL following PKDL reported. 
• LD bodies rich nodular skin lesions -sole reservoir to disseminate in 
absence of zoonotic transmission. 
49
Grey areas in PKDL 
1. The factors of parasite/host origin -drive the parasite to shift from viscera to dermis. --It is 
not known it is the residual parasite after VL infection, attributed to altered immune status or 
is introduced upon re-infection by sandfly vector. 
Antimony therapy for PKDL patients needs to be continued for much longer duration than 
for VL patients (4 months instead of 4 wk for VL). 
• Recently-High interleukin-10 (IL-10) levels in skin & peripheral blood. 
-High level of C reactive protein in plasma of patients with VL 
Predictive of the subsequent development of PKDL. 
50
51
52

Leishmaniasis 120609100101-phpapp01

  • 1.
  • 2.
    What is Kala-Azar • Kala-azar means dark pigmentation which is characteristic of cases of visceral leishmaniasis. It is caused by Leishmania donovani bodies and may be present either in endemic, epidemic or sporadic forms. It is widely prevalent in India in epidemic form in states of Bihar, Assam and Bengal. Kala azar found in East and North Africa is a disease of young children and young adults, being more common in males as compared to females. 2
  • 3.
    World distribution ofVisceral Leishmaniasis 3
  • 4.
    SYNONYMS kala azar,black fever, sandfly disease, Dum-Dum fever 4
  • 5.
    KALA AZAR •Leishmaniasis is a disease caused by protozoan parasites of to the genus Leishmania and is transmitted by the bite of sand fly. • Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with three species (L. donovani, L. infantum, and L. chagasi 5
  • 6.
    Pathogenesis • Infectionsrange from asymptomatic to progressive, fully developed kala-azar. • Incubation period is usually 2 – 4 months. • Symptoms – Begins with low-grade fever and malaise, followed by progressive wasting, anemia, and protrusion of the abdomen from enlarged liver and spleen. • Fatal after 2 – 3 years if not treated. • In acute cases with chills, fevers up to 104⁰ F and vomiting; death may occur within 6 – 12 months. • Immediate cause of death is usually an invasion of a secondary pathogen that the body is unable to combat. 6
  • 7.
    Leishmaniasis is NeglectedDisease • Leishmaniasis is a globally important but neglected disease, affecting approximately two million people every year. For most people, infection results in a slow-to-heal skin ulcer. In others, however, the parasite targets the liver, spleen and bone marrow, leading to over 70,000 deaths annually. 7
  • 8.
    The Parasite •Phylum • Order • Family • Genus Sarcomastigophora Kinetoplastida Trypanosomatidae Leishmania 8
  • 9.
    Leishmania Parasites andDiseases SPECIES Disease Leishmania tropica* Leishmania major* Cutaneous leishmaniasis Leishmania aethiopica Leishmania mexicana Leishmania braziliensis Mucocutaneous leishmaniasis Visceral leishmaniasis Leishmania donovani* Leishmania infantum* Leishmania chagasi 9
  • 10.
    CLASSIFICATION Old world leishmaniasis • Leishmania donovani • L.infantum • L.tropica • L.major • L.aethiopica New world leishmaniasis • L.braziliensis • L.mexicana complex • L.peruviana • L.chagasi 10
  • 11.
    • ALL theleishmania species are morphologically identical to each other. • These are distinguished by • Intrinsic characters • Biochemical characters • Immunological characters 11
  • 12.
    Morphology • Promastigote• Amastigote Flagella Kinetoplast Golgi Nucleus Cytoskeleton 12
  • 13.
    Promastigote & Amastigoteof Leishmania 13
  • 14.
    Morphology • Promastigote – Insect – Motile – Midgut • Amastigote – Mammalian stage – Non-motile – Intracellular Digenetic Life Cycle 14
  • 15.
    • Amastigotes (*) of Leishmania donovani in the cells of a spleen. The individual amastigotes measure approximately 1 μm in diameter. 15
  • 16.
    Morphology and LifeCycle • Amastigotes measure 2-3 micrometers, with a large nucleus and Kinetoplast. • Amastigotes mainly live within cells of the RE system, but have been found in nearly every tissue and fluid of the body. 16
  • 17.
    Life cycle •The organism is transmitted by the bite of several species of blood-feeding sand flies (Phlebotomus) which carries the promastigote in the anterior gut and pharynx. It gains access to mononuclear phagocytes where it transform into amastigote and divides until the infected cell ruptures. 17
  • 18.
  • 19.
    Life cycle •The released organisms infect other cells. The sand-fly acquires the organisms during the blood meal, the Amastigote transform into flagellate Promastigote and multiply in the gut until the anterior gut and pharynx are packed. Dogs and rodents are common reservoirs. 19
  • 20.
    Different stages ofHaemoflagellates 20
  • 21.
    VL - ClinicalManifestation Variable - Incubation 3-100+ weeks Low grade fever Hepato-splenomegaly Bone marrow hyperplasia Anemia , Leucopenia & Cachexia Hypergammaglobulinemia Epistaxis , Proteinuria, Hematuria 21
  • 22.
  • 23.
    • Pallor inhands of a visceral leishmaniasis patient. 23
  • 24.
    Laboratory diagnosis •Blood counts: Anaemia, neutropenia, thrombocytopenia • A/G ratio reversed (n-4.5:2, in kala-azar-2.8:4) • Parasitological Diagnosis • PBF • Needle biopsy/aspiration • Culture • Animal inoculation • Immunological tests • Non-specific tests • Aldehyde tests • Antimony test • A:G Complement fixation test with W.K.K antigen 24
  • 25.
    • Immunological tests • Non-specific test • Aldehyde test • Antimony test • Complement fixation test with W.K.K antigen • Specific tests • Direct agglutination test(DAT) • Indirect haemagglutination test (IHA) • Indirect fluorescent antibody test(IFAT) • ELISA 25
  • 26.
    Parasitological diagnosis: Specimen: Bone marrow aspirate Splenic aspirate Lymph node aspiration Tissue biopsy Microscopy – PBF, Buffy coat smear Culture Animal inoculation- golden hamester 26
  • 27.
    Bone marrow aspiration Bone marrow amastigotes 27
  • 28.
    L. donovani bodies L. donovani bodies may be demonstrated in buffy coat preparations of blood and bone marrow aspirate. PBF is made with straight leucocytic edge Aspirates taken from enlarged lymph nodes show parasites in 60 percent of cases. 28
  • 29.
    Culturing of theParasite • Organisms can be cultured in Nicolle- NovyMcneal (NNN media) media from clinical specimens obtained from splenic or bone marrow aspirates. 29
  • 30.
    Cultivation • NNNmedium-Biphasic media- 2 parts of salt agar+1 part of defibrinated rabbit blood, melted & cooled to 48⁰C ice, inoculated into water of condensation, incubated at 22-25⁰C for the 21 days. • Hockmeyer medium- Insect cell culture medium+ foetal calf serum+ penicillin+ streptomycin( detected after 2-3 d) • Schneider Dorsophila Medium 30
  • 31.
    Promastigote in culturein NNN medium (magnification 100×) NNN culture medium Promastigotes growing in culture medium Bone marrow aspirate -“rosette” of extra-cellular Promastigotes (Giemsa stain31).
  • 32.
    Immunological Diagnosis: •Specific serologic tests: • Direct Agglutination Test (DAT), • ELISA, • IFAT, • CFT for detection of antibodies • Rapid immunochromatic test(ICT): By using rk39Ag • Molecular Methods: PCR & RT-PCR. 32
  • 33.
    Direct agglutination test • Direct agglutination test (DAT) based on agglutination of the trypsinized whole promastigotes is useful in endemic regions. Its sensitivity ranges from 91-100% and specificity from 72 to 100%. 33
  • 34.
    ELISA • ELISAis an important sero diagnostic tool for leishmaniasis. It is a highly sensitive test and its specificity depends upon the antigen used. 34
  • 35.
    Chromatographic strip test • A ready to use immuno chromatographic strip test based on rk 39 antigen has been developed as a rapid test for diagnosis of kala azar. An important limitation of this test is the presence of antibodies in healthy controls hailing from endemic regions. 35
  • 36.
    • Non specificserological tests for hypergammaglobinemia • Napier’s Aldehyde test: Patient’s sera is mixed with a drop of 40% formalin in a test tube. Positive test is indicated by jellification. • Chopra’s antimony test: Positive test is by formation of profuse flocculation when patient ‘ sera is mixed with 4% urea stilbamine solution. 36
  • 37.
    37 Skin test( leishmanin test or Montenegro test) It is a delayed hypersensitivity skin test for survey of populations and follow-up after treatment - 0.2 ml(6-10 million/ml of killed promastigotes in 0.5% phenol saline) injected—erythema ≥ 5mm→ +ve after 6-8 weeks of cure.
  • 38.
    The leishmanin skintest (LST) or MST (Montenegro skin test) PROBLEMS: A positive leishmanin skin test •Reference standards -antigens & performance (reading)- not developed. •Most antigens, crude extracts of parasites, neither sensitive nor specific. •Positivity not demonstrable until 5 months after the acute phase of VL-20% • May or may not be positive for PKDL. •Persistence of the lesions has been frequently associated with non reactivity in the LST and high levels of anti-leishmanial antibodies. 38
  • 39.
    Treatment: • Pentavalentantimony (Pentostam) • Amphotericin B • Miltefosine • Interferon Treatment of complications: • Anemia • Bleeding • Infections etc. 39
  • 40.
    Control • Vectorcontrol • Reservoir control • Treatment of active cases • Vaccination 40
  • 41.
    Management of Kala-azarPatients • It includes both supportive and curative. All patients of Kala azar should preferably be hospitalized. Any infection complicating the disease be treated by use of proper antibiotics. Nutrition must be maintained. Cases with severe anemia may require blood transfusions. Pentavalent antimony compounds are the drug of choice. Sodium antimony gluconate (Pentostam) is the most commonly used drug. 41
  • 42.
    Kala-azar prevention: •Multipronged approach is needed. • Sand-flies are extremely sensitive to insecticides & vector control through insecticide spray is very important. • Mosquito nets or curtains treated with insecticides will keep out the tiny sand-flies. 42
  • 43.
    Kala-azar prevention: •In endemic areas with zoonotic transmission, infected or stray dogs should be destroyed. • In areas with anthroponotic transmission, early diagnosis & treatment of human infections, to reduce the reservoir & control epidemics of VL, is extremely important. • Serology is useful for screening of suspected cases in the field. • No vaccine is currently available . 43
  • 44.
    • NLCP-National leishmaniacontrol programme is to eradicate leishmania by 2015. 44
  • 45.
  • 46.
    Post Kala AzarDermal Leishmanoid Normally develops <2 years after recovery Recrudescence Restricted to skin Rare but varies geographically(10% of cases in India and 3% of cases in Africa) 46
  • 47.
    PKDL •L.donovani •Nonulcerative skin lesin. •Late sequale of VL. •1-2 years after recovery fron VL. •Currently, PKDL is reported to occur in only 1% of Indian VL patient. Nodular skin lesions in PKDL •3 major representations- (i) Erythematous indurated lesions on the butterfly area of face; (ii) Multiple symmetrical hypopigmented macules with irregular margins that may coalesce, having generalized distribution to the extremities and trunk; and (iii) Combination of papules, nodules and plaques. 47
  • 48.
    Fig. Clinical presentationin PKDL (A) PKDL nodular and popular lesions on face and hypopigmented macules on neck in a patient with polymorphic presentation (B) hypopigmented macules on trunk in a patient with macular PKDL. (C) Erythematous and indurated lesions over the butterfly area of face. 48
  • 49.
    Complications of PKDL 1. Blindness due to corneal involvement. 2. Recently, nerve involvement in Indian PKDL reportd. • Nowadays – reported from South America, Europe & India. • Recurrence of VL following PKDL reported. • LD bodies rich nodular skin lesions -sole reservoir to disseminate in absence of zoonotic transmission. 49
  • 50.
    Grey areas inPKDL 1. The factors of parasite/host origin -drive the parasite to shift from viscera to dermis. --It is not known it is the residual parasite after VL infection, attributed to altered immune status or is introduced upon re-infection by sandfly vector. Antimony therapy for PKDL patients needs to be continued for much longer duration than for VL patients (4 months instead of 4 wk for VL). • Recently-High interleukin-10 (IL-10) levels in skin & peripheral blood. -High level of C reactive protein in plasma of patients with VL Predictive of the subsequent development of PKDL. 50
  • 51.
  • 52.